{{medical}}
{{Drugbox | Watchedfields = changed
| verifiedrevid = 443306800
| IUPAC_name = 11β-[''p''-(Dimethylamino)phenyl]-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one
| image = Mifepristone structure.svg
| image2 = Mifepristona3D.png

<!--Clinical data-->
| tradename = Mifeprex
| Drugs.com = {{drugs.com|monograph|mifepristone}}
| MedlinePlus = a600042
| pregnancy_US = X
| pregnancy_category = {{tsl|en|Abortifacient|墮胎藥物}}
| legal_US = Rx-only
| legal_status =Rx-only
| routes_of_administration = [[口服给药|口服给药]]

<!--Pharmacokinetic data-->
| bioavailability = 69%
| protein_bound = 98%
| metabolism = [[肝臟|肝臟]]
| elimination_half-life = 18 小時
| excretion = [[糞便|糞便]]：83%；[[腎|Renal]]：9%

<!--Identifiers-->
<!--| CASNo_Ref = {{cascite|correct|CAS}}-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 84371-65-3
| ATC_prefix = G03
| ATC_suffix = XB01
| PubChem = 55245
| IUPHAR_ligand = 2805
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00834
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 49889
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 320T6RNW1F
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00585
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 50692
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 157

<!--Chemical data-->
| C=29 | H=35 | N=1 | O=2
| molecular_weight = 429.60 g/mol
| SMILES = O=C5\C=C4/C(=C3/[C@@H](c1ccc(N(C)C)cc1)C[C@]2([C@@H](CC[C@]2(C#CC)O)[C@@H]3CC4)C)CC5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VKHAHZOOUSRJNA-GCNJZUOMSA-N
| density = 1.189
| melting_point = 194
| boiling_point = 629
}}

'''美服培酮''' （{{Lang-en|Mifepristone}}，又稱'''RU-486'''；中国称'''米非司酮'''）是一種口服[[墮胎藥|墮胎藥]]，常與[[米索前列醇|米索前列醇]]併用以[[墮胎|終止妊娠]]<ref name=AHFS2015>{{cite web|title=Mifepristone|url=http://www.drugs.com/monograph/mifepristone.html|publisher=The American Society of Health-System Pharmacists|accessdate=December 19, 2015|archive-date=2015-12-22|archive-url=https://web.archive.org/web/20151222083002/http://www.drugs.com/monograph/mifepristone.html|dead-url=no}}</ref>。這種配方在[[妊娠|妊娠]]前50天有95%的成功率<!-- <ref name=Rex2012/> -->，在[[妊娠#懷孕中期|懷孕中期]]也相當有效 <ref name=Rex2012/><ref>{{cite journal|last1=Wildschut|first1=H|last2=Both|first2=MI|last3=Medema|first3=S|last4=Thomee|first4=E|last5=Wildhagen|first5=MF|last6=Kapp|first6=N|title=Medical methods for mid-trimester termination of pregnancy.|journal=The Cochrane database of systematic reviews|date=19 January 2011|issue=1|pages=CD005216|pmid=21249669|doi=10.1002/14651858.CD005216.pub2}}</ref>。在施藥後兩週需要追蹤以確認效果<ref name=AHFS2015/>。

<!-- Side effects -->
常見的副作用包含腹痛、疲倦和陰道出血。嚴重的副作用可能有大量陰道出血<!-- <ref name=AHFS2015/> -->、細菌感染和妊娠未中止的胎兒畸形<!-- <ref name=AHFS2015/> -->。使用後需要有適當的後續追蹤及照護<!-- <ref name=AHFS2015/> -->。它作用的機轉是拮抗[[黃體素|黃體素]]的作用，並造成子宮收縮<ref name=AHFS2015/>。

<!-- History, society and culture -->
美服培酮開發於1980年，1987年法國開始使用此款藥品<ref>{{cite book|last1=Corey|first1=E.J.|title=Molecules and Medicine|date=2012|publisher=John Wiley & Sons|isbn=9781118361733|url=https://books.google.ca/books?id=jz2GN6DYoOoC&pg=RA1-PT108|chapter=Mifepristone|access-date=2016-10-07|archive-date=2019-06-14|archive-url=https://web.archive.org/web/20190614141119/https://books.google.ca/books?id=jz2GN6DYoOoC&pg=RA1-PT108|dead-url=no}}</ref>，美國則在2000年時核准美服培酮的上市<ref name=Rex2012>{{cite book|last1=Rexrode|first1=edited by Marlene Goldman, Rebecca Troisi, Kathryn|title=Women and health|date=2012|publisher=Academic|location=Oxford|isbn=9780123849793|page=236|edition=2nd|url=https://books.google.ca/books?id=mavb4v8w8bsC&pg=PA236|access-date=2016-10-07|archive-date=2019-06-10|archive-url=https://web.archive.org/web/20190610110417/https://books.google.ca/books?id=mavb4v8w8bsC&pg=PA236|dead-url=no}}</ref>。本品列名於[[世界衛生組織基本藥物標準清單|世界衛生組織基本藥物標準清單]]之中，為基礎醫療系統內的必備藥品<ref name=WHO2015E>{{cite web |url=http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf |title=19th WHO Model List of Essential Medicines (April 2015) |date=April 2015 |accessdate=May 10, 2015 |publisher=WHO |archive-date=2015-05-13 |archive-url=https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf |dead-url=no }}</ref>。[[加拿大衛生部|加拿大衛生部]]於2015年7月核准本品，並於2016年7月上市<ref>{{cite web|last1=Paperny|first1=Anna Mehler|date=April 5, 2016|title=Abortion pill: Canadian prescribers to get training for Mifegymiso this month|url=http://globalnews.ca/news/2619664/abortion-pill-canadian-prescribers-to-get-training-for-mifegymiso-this-month/|website=Global News|accessdate=10 June 2016|archive-date=2016-09-27|archive-url=https://web.archive.org/web/20160927200409/http://globalnews.ca/news/2619664/abortion-pill-canadian-prescribers-to-get-training-for-mifegymiso-this-month/|dead-url=no}}</ref><ref>{{cite news|last=Kirkey|first=Sharon|date=April 19, 2016|title=Home abortion pill about to hit market in Canada, but has already garnered criticism|newspaper=National Post|url=http://news.nationalpost.com/news/canada/0420-na-abortion|accessdate=June 26, 2016|quote=expected to become available in July.|archive-date=2017-05-13|archive-url=https://web.archive.org/web/20170513130026/http://news.nationalpost.com/news/canada/0420-na-abortion|dead-url=no}}</ref>。在部分開發中國家美服培酮的成本與獲取仍舊受到許多限制<ref>{{cite book|last1=Hussein|first1=edited by Julia|last2=McCaw-Binns,|first2=Affette|last3=Webber|first3=Roger|title=Maternal and perinatal health in developing countries|date=2012|publisher=CABI|location=Wallingford, Oxfordshire|isbn=9781845937461|page=104|url=https://books.google.ca/books?id=BlRMxAOSeNIC&pg=PA104|access-date=2016-10-07|archive-date=2020-02-04|archive-url=https://web.archive.org/web/20200204144729/https://books.google.ca/books?id=BlRMxAOSeNIC&pg=PA104|dead-url=no}}</ref><ref>{{cite journal|last1=Winikoff|first1=B|last2=Sheldon|first2=W|title=Use of medicines changing the face of abortion.|journal=International perspectives on sexual and reproductive health|date=September 2012|volume=38|issue=3|pages=164–6|pmid=23018138|doi=10.1363/3816412}}</ref>。單劑美服培酮在美國當地的售價更超過{{USD|200|2015}}<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=368}}</ref>。

==簡介==
1980年[[法國|法國]]製藥公司{{Internal link helper/en|Roussel Uclaf|Roussel Uclaf}}的研究人員已發現了美服培酮，當時他們正在研究{{Internal link helper/en|糖皮質激素受體|Glucocorticoid receptor}}拮抗劑。{{Internal link helper/en|艾蒂安·埃米爾·鮑利厄|Étienne-Émile Baulieu}}發現了它的黃體素拮抗作用，可以用作[[墮胎|墮胎]]。[[黃體素|黃體素]]是維持懷孕必不可少的激素，美服培酮與[[黃體素受體|黃體素受體]]競爭，抑制了黃體素的作用，造成子宮肌收縮，子宮頸軟化擴大，月經會隨之而來，胚胎會被排出身體流產。<ref name="fda"/><ref name="leda">{{cite web|author=Julie A. Hogan|title=The Life of the Abortion Pill in the United States|publisher=Legal Electronic Document Archive, Harvard Law School|year=2000|accessdate=2006-09-14|url=http://leda.law.harvard.edu/leda/search/toc.php3?handle=HLS.Library.Leda/hoganja-life_abortion_pill|deadurl=yes|archiveurl=https://web.archive.org/web/20060905092818/http://leda.law.harvard.edu/leda/search/toc.php3?handle=HLS.Library.Leda%2Fhoganja-life_abortion_pill|archivedate=2006-09-05}}</ref>美服培酮在1982年開始臨床試驗，1988年在[[法國|法國]]獲得批准配合[[前列腺素|前列腺素]]使用，其當時品牌名稱為Mifegyne。

{{Citation needed|此藥在獲得批准但還沒有推出市面上時，Roussel Uclaf因受到反墮胎人士的壓力及杯葛威脅曾聲言放棄分銷此藥。但是兩日後，法國政府，也是Roussel Uclaf藥廠股東之一，出面干涉，此藥才得以繼續生產及分銷。法國衛生部長聲明：“我不能夠讓墮胎的爭議去剝奪女性使用象徵醫學進步的藥品的權利。從這一刻開始，政府認可此藥，而此藥也是女性合乎道德規範的財寶。|time=2021-03-08T16:35:36+00:00}}

其後，[[中國大陸|中國大陸]]、[[英國|英國]]、[[瑞典|瑞典]]、[[美國|美國]]、[[台灣|台灣]]相繼獲得批准。

==使用方法==
RU486是屬於醫師的處方用藥，不可以自行服用。服用的方式有單次或是分次的方式，同時也要服用[[前列腺素|前列腺素]]才能增加成功率，如果肝、腎功能不健全、對前列腺素過敏、有心血管疾病、[[高血壓|高血壓]]等等就不很適合服用。如果服藥不當可能會有小問題變成致命的殺手<ref>{{Cite web |url=http://www.obsgyn.net/index.htm |title=女人心事秘密花園 |accessdate=2012-01-30 |archive-date=2012-01-24 |archive-url=https://web.archive.org/web/20120124020824/http://www.obsgyn.net/index.htm |dead-url=no }}</ref>。

==副作用==
接受單一劑量的RU486來進行早期[[妊娠|妊娠]]的墮胎時，很少會出現副作用，頂多也只是噁心、嘔吐、暈眩、腹痛、疲倦，以及出血量稍多<ref name="妹妹">{{Cite web |url=http://intermargins.net/repression/deviant/Marriage/fornicator/abortion/articles/ru486facts.htm |title=RU486手冊 |accessdate=2012-01-10 |archive-date=2012-01-06 |archive-url=https://web.archive.org/web/20120106220613/http://intermargins.net/repression/deviant/Marriage/fornicator/abortion/articles/ru486facts.htm |dead-url=no }}</ref>。注意事項：未生育過的女性，由於產道沒有擴張過，如果在沒有醫師指導及足夠的醫療設備監視下使用，可能會導致不完全流產的大出血（[[血崩|血崩]]）危險。
RU486是一種口服藥物，可替代外科手術來終止[[子宮|子宮]]內懷孕，依國外規定，通常是在最後一次月經週期的第1天算起49天內使用。但是使用醫院必須要有適當經驗的醫師與足夠的甦醒設備，服用後，病人應留置觀察至少2小時。而且使用RU486後6至10天內，患者必須用臨床檢驗、超音波等適當方式確認是否墮胎完全，若陰道仍持續出血，可能是墮胎不完全，必須給予適當的處置<ref name="妹妹" />。

==參考文獻==
{{reflist|30em}}

==外部連結==
* [http://www.xjpharma.com/pro_desc_34_95_1338.html 含珠停（米非司酮片）-浙江仙琚制药股份有限公司]  
* [http://www.ru486.com/topics/articles/article_73.asp Commonly asked questions about RU-486] {{Wayback|url=http://www.ru486.com/topics/articles/article_73.asp |date=20080729201538 }} from the education arm of the {{tsl|en|National Coalition of Abortion Providers||National Coalition of Abortion Providers}}
* [http://www.earlyoptionpill.com/ Danco product web site – EarlyOptionPill.com]
* [https://web.archive.org/web/20051211142330/http://www.earlyoptionpill.com/pdfs/prescribing071905.pdf Danco prescribing information]
* [http://www.ru486.org.au Australians for RU-486] {{Wayback|url=http://www.ru486.org.au/ |date=20150227090848 }} – established in February 2006 to lobby for passage of bill in Australia's Parliament to enable the availability of mifepristone

{{Progestogens and antiprogestogens}}
{{Glucocorticoids and antiglucocorticoids}}
{{Abortion}}
{{Androgenics}}
{{Glucocorticoid receptor modulators}}

{{Nuclear receptor modulators}}
{{Serotonergics}}

{{tsl|en|Category:Antiglucocorticoids||Category:Antiglucocorticoids}}
{{tsl|en|Category:Antiprogestogens||Category:Antiprogestogens}}
{{tsl|en|Category:Methods of abortion||Category:Methods of abortion}}
{{tsl|en|Category:Pregnane X receptor agonists||Category:Pregnane X receptor agonists}}
{{tsl|en|Category:Serotonin reuptake inhibitors||Category:Serotonin reuptake inhibitors}}

[[Category:堕胎药|Category:堕胎药]]
[[Category:抗雄激素物质|Category:抗雄激素物质]]
[[Category:炔烃|Category:炔烃]]
[[Category:苯胺|Category:苯胺]]
[[Category:堕胎|Category:堕胎]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:法國發明|Category:法國發明]]